Amylyx Pharmaceuticals' (AMLX) Relyvrio Receives Approval from FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: AMLX) | Delayed: 27.50 -1.07 (3.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.57 | 52 Week High | $ | |||
| Open | $28.46 | 52 Week Low | $ | |||
| Day High | $28.46 | P/E | N/A | |||
| Day Low | $27.45 | EPS | $ | |||
| Volume | 657,924 | |||||
